We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

D.C. Circuit Rejects Mylan's Bid To Make Generic Duragesic

Law360 (December 7, 2004, 12:00 AM EST) -- A U.S. appeals court in Washington, D.C. has rejected Mylan Laboratories' bid to market a generic version of Johnson & Johnson's Duragesic pain-relief skin patch.

The United States Court of Appeals...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.